BACKGROUND: Recent and previous studies have shown that guinea pigs can be infected with, and transmit, human influenza viruses. Therefore guinea pig may be a useful animal model for better understanding influenza infection and assessing vaccine strategies. To more fully characterize the model, antibody responses following either infection/re-infection with human influenza A/Wyoming/03/2003 H3N2 or immunization with its homologous recombinant hemagglutinin (HA) protein were studied. RESULTS: Serological samples were collected and tested for anti-HA immunoglobulin by ELISA, antiviral antibodies by hemagglutination inhibition (HI), and recognition of linear epitopes by peptide scanning (PepScan). Animals inoculated with infectious virus demonstrated pronounced viral replication and subsequent serological conversion. Animals either immunized with the homologous HA antigen or infected, showed a relatively rapid rise in antibody titers to the HA glycoprotein in ELISA assays. Antiviral antibodies, measured by HI assay, were detectable after the second inoculation. PepScan data identified both previously recognized and newly defined linear epitopes. CONCLUSIONS: Infection and/or recombinant HA immunization of guinea pigs with H3N2 Wyoming influenza virus resulted in a relatively rapid production of viral-specific antibody thus demonstrating the strong immunogenicity of the major viral structural proteins in this animal model for influenza infection. The sensitivity of the immune response supports the utility of the guinea pig as a useful animal model of influenza infection and immunization.
BACKGROUND: Recent and previous studies have shown that guinea pigs can be infected with, and transmit, human influenza viruses. Therefore guinea pig may be a useful animal model for better understanding influenza infection and assessing vaccine strategies. To more fully characterize the model, antibody responses following either infection/re-infection with humaninfluenza A/Wyoming/03/2003 H3N2 or immunization with its homologous recombinant hemagglutinin (HA) protein were studied. RESULTS: Serological samples were collected and tested for anti-HA immunoglobulin by ELISA, antiviral antibodies by hemagglutination inhibition (HI), and recognition of linear epitopes by peptide scanning (PepScan). Animals inoculated with infectious virus demonstrated pronounced viral replication and subsequent serological conversion. Animals either immunized with the homologous HA antigen or infected, showed a relatively rapid rise in antibody titers to the HA glycoprotein in ELISA assays. Antiviral antibodies, measured by HI assay, were detectable after the second inoculation. PepScan data identified both previously recognized and newly defined linear epitopes. CONCLUSIONS:Infection and/or recombinant HA immunization of guinea pigs with H3N2 Wyoming influenza virus resulted in a relatively rapid production of viral-specific antibody thus demonstrating the strong immunogenicity of the major viral structural proteins in this animal model for influenza infection. The sensitivity of the immune response supports the utility of the guinea pig as a useful animal model of influenza infection and immunization.
Authors: Gregory J Tobin; Jessie D Trujillo; Ruth V Bushnell; George Lin; A Ray Chaudhuri; Jinxue Long; Jose Barrera; Lindomar Pena; Marvin J Grubman; Peter L Nara Journal: Vaccine Date: 2008-10-11 Impact factor: 3.641
Authors: Neal Van Hoeven; Jessica A Belser; Kristy J Szretter; Hui Zeng; Peter Staeheli; David E Swayne; Jacqueline M Katz; Terrence M Tumpey Journal: J Virol Date: 2009-01-14 Impact factor: 5.103
Authors: Jan Willem van der Laan; Carla Herberts; Robert Lambkin-Williams; Alison Boyers; Alexander J Mann; John Oxford Journal: Expert Rev Vaccines Date: 2008-08 Impact factor: 5.217
Authors: Christian Billich; Christian Sauder; Ronald Frank; Sibylle Herzog; Karl Bechter; Kazuo Takahashi; Helmut Peters; Peter Staeheli; Martin Schwemmle Journal: Biol Psychiatry Date: 2002-06-15 Impact factor: 13.382
Authors: Hongying Chen; Xiaodong Xu; Hsin-Hui Lin; Ssu-Hsien Chen; Anna Forsman; Marlen Aasa-Chapman; Ian M Jones Journal: J Gen Virol Date: 2008-10 Impact factor: 3.891
Authors: Jinxue Long; Ruth V Bushnell; John K Tobin; Keyao Pan; Michael W Deem; Peter L Nara; Gregory J Tobin Journal: PLoS One Date: 2011-07-22 Impact factor: 3.240
Authors: Dorota Smolarek; Claude Hattab; Anna Buczkowska; Radoslaw Kaczmarek; Anna Jarząb; Sylvie Cochet; Alexandre G de Brevern; Jolanta Lukasiewicz; Wojciech Jachymek; Tomasz Niedziela; Magdalena Grodecka; Kazimiera Wasniowska; Yves Colin Aronovicz; Olivier Bertrand; Marcin Czerwinski Journal: PLoS One Date: 2015-02-23 Impact factor: 3.240